financetom
Business
financetom
/
Business
/
US says Gates-backed reactor company's planned application needs work
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US says Gates-backed reactor company's planned application needs work
Mar 22, 2024 9:24 AM

WASHINGTON (Reuters) - U.S. regulators this week told a nuclear power company founded by Bill Gates that its planned construction permit application for a high-tech reactor needs more work, an issue that a critic of the technology said could delay development of the plant in Wyoming.

TerraPower LLC, is trying to build the $4 billion Natrium reactor in Wyoming on the site of an old coal plant. The permit application is expected this month.

So-called advanced nuclear reactors like Natrium that use new materials and fuel types are supported by the administration of President Joe Biden as a potential way to fight climate change. The U.S. Department of Energy has authorized up to $2 billion of taxpayer money for the Natrium project.

The U.S. Nuclear Regulatory Commission on March 19 sent TerraPower a 40-page overview of a "pre-application readiness assessment" of safety and environmental issues for the reactor. TerraPower had asked NRC for the assessment ahead of its construction permit application.

The NRC told TerraPower that the company made several references to technical and licensing reports that its staff has not yet reviewed or that are currently under review.

"References to reports for which the reviews have not yet been completed represents a potential (construction permit) application review schedule risk," the NRC said in the letter.

"The NRC review shows that the Natrium construction permit application is simply not ready for prime time," said Edwin Lyman, a physicist and nuclear power safety advocate at the Union of Concerned Scientists nonprofit group.

"TerraPower should take the time to produce a complete, high-quality application. Otherwise, the Wyoming project is likely to encounter costly delays," Lyman said.

A TerraPower spokesperson said the readiness assessment was a tool to evaluate the completeness of its forthcoming construction permit application and that its timeline is on track.

"TerraPower will be the first company to submit a commercial advanced nuclear power reactor to the NRC and we feel confident in our timeline to submit this application to the NRC this month," they said.

The spokesperson added that "the NRC states in the letter their confidence that TerraPower can supply additional information where needed in the official construction permit application."

The review questions how TerraPower will demonstrate that the materials used to construct the plant will survive harsh conditions over its operating life, Lyman said.

The reactor will be cooled with liquid sodium, instead of water used by today's reactors.

TerraPower in late 2022 delayed Natrium's launch date by at least two years to 2030 due to a lack of special fuel called high assay low enriched uranium, or HALEU. Russia has been the only supplier of HALEU, but TerraPower and Centrus Energy Corp ( LEU ) are trying to establish commercial production capabilities for the 2030 start.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hyundai to use $3 bln record India IPO proceeds for new cars, R&D
Hyundai to use $3 bln record India IPO proceeds for new cars, R&D
Oct 9, 2024
* Hyundai IPO biggest ever in India, Asia's biggest in 2024 * Company wants to expand in India; first listing outside S.Korea * Hyundai aims to make India a manufacturing hub for emerging mkts * Executive says 30% increase in production seen in 3-4 years (Adds details, comments in paragraph 7, 11, 16-17) By Dhwani Pandya MUMBAI, Oct 9 (Reuters)...
Capricor Therapeutics Submits Biologics License Application to FDA for Duchenne Muscular Dystrophy Drug Candidate
Capricor Therapeutics Submits Biologics License Application to FDA for Duchenne Muscular Dystrophy Drug Candidate
Oct 9, 2024
10:00 AM EDT, 10/09/2024 (MT Newswires) -- Capricor Therapeutics ( CAPR ) said Wednesday that it has initiated a rolling submission with the US Food and Drug Administration for a biologics license application for deramiocel to treat patients with Duchenne muscular dystrophy cardiomyopathy. The biotech company said it expects to complete the rolling submission by the end of the year...
Theratechnologies to Present Data Next Week Highlighting Advances in Treatment in People with HIV
Theratechnologies to Present Data Next Week Highlighting Advances in Treatment in People with HIV
Oct 9, 2024
08:01 AM EDT, 10/09/2024 (MT Newswires) -- Theratechnologies ( THTX ) on Wednesday announced three poster presentations at IDWeek 2024 taking place next week in Los Angeles. One poster presents data linking excess visceral abdominal fat (EVAF) to increased cardiovascular risk in people with HIV, while a second poster documents how use of tesamorelin, a growth hormone-releasing factor analog, to...
Safety Shot Rebrands as Sure Shot
Safety Shot Rebrands as Sure Shot
Oct 9, 2024
08:59 AM EDT, 10/09/2024 (MT Newswires) -- Safety Shot ( SHOT ) said Wednesday it has rebranded as Sure Shot. The company said it teamed up with full-service agency Amalgam, which led the rebranding effort in partnership with Stout Design. Price: 1.2795, Change: +0.02, Percent Change: +1.55 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved